NFCR research on childhood cancer
The Future of Childhood Cancer Research
Children need treatments developed with their cancers and their growing bodies in mind. Research aims to find more effective approaches while addressing the lasting effects that treatment can have. Studies of pediatric tumors and engineered immune cells offer different routes toward that goal.
What NFCR Is Doing
We support research into treatments for childhood cancers that remain difficult to treat. Cesare Spadoni investigates drug combinations for medulloblastoma and rhabdomyosarcoma. We also supported Laurence Cooper’s work on engineering T cells to recognize CD19-positive leukemia and lymphoma cells. These projects address different diseases and stages of research; they do not represent a single treatment for all children.
- Year we began supporting Cesare Spadoni
- 2017
- Funding period for Laurence Cooper
- 2004–2015
- Pediatric cancers at the forefront of Spadoni’s research: medulloblastoma and rhabdomyosarcoma
- 2